541 related articles for article (PubMed ID: 27681997)
1. Molecular and clinical features of K
Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
[TBL] [Abstract][Full Text] [Related]
2. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
[TBL] [Abstract][Full Text] [Related]
3. Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation.
Ozsu E; Giri D; Seymen Karabulut G; Senniappan S
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1403-1406. PubMed ID: 27849623
[TBL] [Abstract][Full Text] [Related]
4. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.
Li X; Xu A; Sheng H; Ting TH; Mao X; Huang X; Jiang M; Cheng J; Liu L
Pediatr Diabetes; 2018 Mar; 19(2):251-258. PubMed ID: 28791793
[TBL] [Abstract][Full Text] [Related]
5. DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea.
Cho JH; Kang E; Lee BH; Kim GH; Choi JH; Yoo HW
J Korean Med Sci; 2017 Jun; 32(6):1042-1045. PubMed ID: 28480665
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation of K
Gopi S; Kavitha B; Kanthimathi S; Kannan A; Kumar R; Joshi R; Kanodia S; Arya AD; Pendsey S; Pendsey S; Raghupathy P; Mohan V; Radha V
Pediatr Diabetes; 2021 Feb; 22(1):82-92. PubMed ID: 32893419
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
Shimomura K; Hörster F; de Wet H; Flanagan SE; Ellard S; Hattersley AT; Wolf NI; Ashcroft F; Ebinger F
Neurology; 2007 Sep; 69(13):1342-9. PubMed ID: 17652641
[TBL] [Abstract][Full Text] [Related]
8. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.
Mancioppi V; Pozzi E; Zanetta S; Missineo A; Savastio S; Barbetti F; Mellone S; Giordano M; Rabbone I
Front Endocrinol (Lausanne); 2023; 14():1143736. PubMed ID: 37251668
[TBL] [Abstract][Full Text] [Related]
9. Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.
Slingerland AS; Nuboer R; Hadders-Algra M; Hattersley AT; Bruining GJ
Diabetologia; 2006 Nov; 49(11):2559-63. PubMed ID: 17047922
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of activating mutations in the sulfonylurea receptor 1 (ABCC8) causing neonatal diabetes mellitus in Asian Indian children.
Balamurugan K; Kavitha B; Yang Z; Mohan V; Radha V; Shyng SL
Pediatr Diabetes; 2019 Jun; 20(4):397-407. PubMed ID: 30861254
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.
Zhang M; Chen X; Shen S; Li T; Chen L; Hu M; Cao L; Cheng R; Zhao Z; Luo F
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):877-84. PubMed ID: 25781672
[TBL] [Abstract][Full Text] [Related]
12. Methods for Characterizing Disease-Associated ATP-Sensitive Potassium Channel Mutations.
Kandasamy B; Shyng SL
Methods Mol Biol; 2018; 1684():85-104. PubMed ID: 29058186
[TBL] [Abstract][Full Text] [Related]
13. Update of variants identified in the pancreatic β-cell K
De Franco E; Saint-Martin C; Brusgaard K; Knight Johnson AE; Aguilar-Bryan L; Bowman P; Arnoux JB; Larsen AR; Sanyoura M; Greeley SAW; Calzada-León R; Harman B; Houghton JAL; Nishimura-Meguro E; Laver TW; Ellard S; Del Gaudio D; Christesen HT; Bellanné-Chantelot C; Flanagan SE
Hum Mutat; 2020 May; 41(5):884-905. PubMed ID: 32027066
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY
Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677
[TBL] [Abstract][Full Text] [Related]
15. Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant.
Siklar Z; Ellard S; Okulu E; Berberoğlu M; Young E; Savaş Erdeve S; Mungan IA; Hacihamdioğlu B; Erdeve O; Arsan S; Oçal G
J Pediatr Endocrinol Metab; 2011; 24(11-12):1077-80. PubMed ID: 22308870
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected].
Busiah K; Drunat S; Vaivre-Douret L; Bonnefond A; Simon A; Flechtner I; Gérard B; Pouvreau N; Elie C; Nimri R; De Vries L; Tubiana-Rufi N; Metz C; Bertrand AM; Nivot-Adamiak S; de Kerdanet M; Stuckens C; Jennane F; Souchon PF; Le Tallec C; Désirée C; Pereira S; Dechaume A; Robert JJ; Phillip M; Scharfmann R; Czernichow P; Froguel P; Vaxillaire M; Polak M; Cavé H;
Lancet Diabetes Endocrinol; 2013 Nov; 1(3):199-207. PubMed ID: 24622368
[TBL] [Abstract][Full Text] [Related]
17. Glycemic control and motor development in a patient with intermediate DEND.
Oka H; Suzuki S; Furuya A; Matsuo K; Amamiya S; Oshima M; Oka T; Mukai T; Okayama A; Araki A; Azuma H; Tanahashi Y
Pediatr Int; 2014 Jun; 56(3):432-5. PubMed ID: 24894933
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M
Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029
[TBL] [Abstract][Full Text] [Related]
19. Genetic characteristics, clinical spectrum, and incidence of neonatal diabetes in the Emirate of AbuDhabi, United Arab Emirates.
Deeb A; Habeb A; Kaplan W; Attia S; Hadi S; Osman A; Al-Jubeh J; Flanagan S; DeFranco E; Ellard S
Am J Med Genet A; 2016 Mar; 170(3):602-9. PubMed ID: 26463504
[TBL] [Abstract][Full Text] [Related]
20. Patient with iDEND syndrome-related mutation.
Prado-Carro AM; Calzada-Hernández J; Marín S; Cardona-Hernandez R; Oriola J; Nicolás M; Ramon-Krauel M
Diabetes Care; 2014 Jun; 37(6):e123-4. PubMed ID: 24855163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
